Chorokbaem Healthcare Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.007x

Chorokbaem Healthcare Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) has a cash flow conversion efficiency ratio of 0.007x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩980.30 Million ≈ $664.33K USD) by net assets (₩137.68 Billion ≈ $93.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Chorokbaem Healthcare Co Ltd (2013–2025)

Cash flow conversion efficiency of Chorokbaem Healthcare Co Ltd from 2013 to 2025. This chart illustrates how Chorokbaem Healthcare Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Chorokbaem Healthcare Co Ltd for real-time trading data and today's change.

Chorokbaem Healthcare Co Ltd Cash Flow Conversion Ratio Explained

Chorokbaem Healthcare Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Chorokbaem Healthcare Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chorokbaem Healthcare Co Ltd ranked by their cash flow conversion efficiency. Also see 118000 market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Clean Energy Technologies, Inc. Common Stock
NASDAQ:CETY
-0.138x
LIGHTON
PA:ALTAI
-0.737x
Arita Prima Indonesia Tbk
JK:APII
0.022x
Mustera Property Group Ltd
AU:MPX
0.201x
Morien Resources Corp
V:MOX
0.527x
Oakley Capital Investments Limited
LSE:OCI
-0.052x
Vakif Menkul Kiymet Yatirim Ortakligi AS
IS:VKFYO
-0.031x
Acceleware Ltd
V:AXE
0.023x

Annual Cash Flow Conversion Efficiency for Chorokbaem Healthcare Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Chorokbaem Healthcare Co Ltd from 2013 to 2025. Review 118000 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩120.98 Billion
≈ $81.99 Million
₩2.42 Billion
≈ $1.64 Million
0.020x -47.82%
2024-12-31 ₩116.80 Billion
≈ $79.15 Million
₩4.48 Billion
≈ $3.03 Million
0.038x +141.05%
2023-12-31 ₩137.70 Billion
≈ $93.32 Million
₩-12.86 Billion
≈ $-8.71 Million
-0.093x -378.38%
2022-12-31 ₩129.58 Billion
≈ $87.81 Million
₩-2.53 Billion
≈ $-1.71 Million
-0.020x -56.24%
2021-12-31 ₩119.40 Billion
≈ $80.92 Million
₩-1.49 Billion
≈ $-1.01 Million
-0.012x -125.06%
2020-12-31 ₩76.13 Billion
≈ $51.59 Million
₩3.79 Billion
≈ $2.57 Million
0.050x +43.90%
2019-12-31 ₩35.94 Billion
≈ $24.35 Million
₩1.24 Billion
≈ $843.66K
0.035x +123.68%
2018-12-31 ₩18.51 Billion
≈ $12.54 Million
₩-2.71 Billion
≈ $-1.84 Million
-0.146x +78.43%
2017-12-31 ₩18.71 Billion
≈ $12.68 Million
₩-12.69 Billion
≈ $-8.60 Million
-0.678x -87.81%
2016-12-31 ₩13.44 Billion
≈ $9.11 Million
₩-4.85 Billion
≈ $-3.29 Million
-0.361x +37.24%
2015-12-31 ₩6.19 Billion
≈ $4.19 Million
₩-3.56 Billion
≈ $-2.41 Million
-0.575x +8.39%
2014-12-31 ₩8.32 Billion
≈ $5.64 Million
₩-5.22 Billion
≈ $-3.54 Million
-0.628x -4003.37%
2013-12-31 ₩16.04 Billion
≈ $10.87 Million
₩258.12 Million
≈ $174.92K
0.016x --

About Chorokbaem Healthcare Co Ltd

KO:118000 Korea Drug Manufacturers - General
Market Cap
$10.88 Million
₩16.06 Billion KRW
Market Cap Rank
#26705 Global
#2010 in Korea
Share Price
₩935.00
Change (1 day)
-3.91%
52-Week Range
₩222.00 - ₩2080.00
All Time High
₩13800.00
About

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more